Wu et al. develop an ultrasensitive immunoassay based on the single-molecule array (SiMoA) technology to detect p53 aggregates in plasma. They show that the p53 aggregate concentrations in the plasma of pre-surgery glioblastoma patients are significantly higher compared to controls.
- Yunzhao Wu
- Jeff Y. L. Lam
- David Klenerman
